Equities Analysts Offer Predictions for RGLS Q1 Earnings
Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Regulus Therapeutics in a research note issued on Wednesday, April 30th. Leerink Partnrs analyst J. Schwartz anticipates that the biopharmaceutical company will post earnings per share of ($0.23) for […]
Regulus Therapeutics Inc. (NASDAQ:RGLS – Free Report) – Equities research analysts at Leerink Partnrs issued their Q1 2025 earnings per share (EPS) estimates for shares of Regulus Therapeutics in a research note issued on Wednesday, April 30th. Leerink Partnrs analyst J. Schwartz anticipates that the biopharmaceutical company will post earnings per share of ($0.23) for […]
-logo-1200x675.png?v=20230221134904&w=240&h=240&zc=2){kind=logo}
